Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation.
作者信息
Corti Alessandro, Gaucher Caroline, Pompella Alfonso
机构信息
Dipartimento di Ricerca Traslazionale NTMC, Scuola Medica dell'Università di Pisa, Pisa, Italy.
Université de Lorraine, CITHEFOR, Nancy, France.
出版信息
Front Pharmacol. 2020 Feb 14;11:86. doi: 10.3389/fphar.2020.00086. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation.社论：靶向单核细胞/巨噬细胞治疗动脉粥样硬化炎症
Front Pharmacol. 2020 Feb 14;11:86. doi: 10.3389/fphar.2020.00086. eCollection 2020.
2
The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis.单核细胞/巨噬细胞在动脉粥样硬化相关慢性炎症中的作用。
Immunobiology. 2013 Nov;218(11):1376-84. doi: 10.1016/j.imbio.2013.06.005. Epub 2013 Jun 19.
3
Ex vivo foam cell formation is enhanced in monocytes from older individuals by both extrinsic and intrinsic mechanisms.通过外在和内在机制，老年个体单核细胞的体外泡沫细胞形成增强。
Exp Gerontol. 2016 Jul;80:17-26. doi: 10.1016/j.exger.2016.04.006. Epub 2016 Apr 9.
4
EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.EphA2表达调控动脉粥样硬化中的炎症和纤维增生性重塑。
Circulation. 2017 Aug 8;136(6):566-582. doi: 10.1161/CIRCULATIONAHA.116.026644. Epub 2017 May 9.
5
Identification of macrophages and smooth muscle cells with monoclonal antibodies in the human atherosclerotic plaque.用人单克隆抗体鉴定人类动脉粥样硬化斑块中的巨噬细胞和平滑肌细胞。
Virchows Arch A Pathol Anat Histopathol. 1987;412(2):169-74. doi: 10.1007/BF00716190.
6
Porphyromonas gingivalis lipopolysaccharide alters atherosclerotic-related gene expression in oxidized low-density-lipoprotein-induced macrophages and foam cells.牙龈卟啉单胞菌脂多糖改变氧化型低密度脂蛋白诱导的巨噬细胞和泡沫细胞中动脉粥样硬化相关基因的表达。
J Periodontal Res. 2011 Aug;46(4):427-37. doi: 10.1111/j.1600-0765.2011.01356.x. Epub 2011 Mar 21.
7
A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis.胰高血糖素样肽-1类似物利拉鲁肽可抑制巨噬细胞泡沫细胞形成及动脉粥样硬化。
Peptides. 2014 Apr;54:19-26. doi: 10.1016/j.peptides.2013.12.015. Epub 2014 Jan 10.
8
Immunological aspects of atherosclerosis.动脉粥样硬化的免疫学方面
Physiol Res. 2014;63(Suppl 3):S335-42. doi: 10.33549/physiolres.932858.
9
The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis.单核细胞和巨噬细胞的表观遗传记忆作为动脉粥样硬化的新型药物靶点。
Clin Ther. 2015 Apr 1;37(4):914-23. doi: 10.1016/j.clinthera.2015.01.008. Epub 2015 Feb 20.
10
Impact of Macrophages in Atherosclerosis.巨噬细胞在动脉粥样硬化中的作用
Curr Med Chem. 2016;23(18):1926-37. doi: 10.2174/0929867323666160428105111.
引用本文的文献
1
Artesunate attenuates foam cell formation by enhancing cholesterol efflux.青蒿琥酯通过增强胆固醇外流来减轻泡沫细胞形成。
Ann Transl Med. 2021 Sep;9(17):1379. doi: 10.21037/atm-21-3551.
本文引用的文献
1
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.白细胞介素-1β作为动脉粥样硬化治疗靶点：CANTOS研究及其他的生物学基础
J Am Coll Cardiol. 2017 Oct 31;70(18):2278-2289. doi: 10.1016/j.jacc.2017.09.028.
2
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
3
Is Coronary Atherosclerosis One Disease or Many? Setting Realistic Expectations for Precision Medicine.冠状动脉粥样硬化是一种疾病还是多种疾病？对精准医学设定现实期望。
Circulation. 2017 Mar 14;135(11):1005-1007. doi: 10.1161/CIRCULATIONAHA.116.026479.
4
Vascular Smooth Muscle Cells in Atherosclerosis.动脉粥样硬化中的血管平滑肌细胞
Circ Res. 2016 Feb 19;118(4):692-702. doi: 10.1161/CIRCRESAHA.115.306361.
5
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis.动脉粥样硬化与动脉平滑肌细胞：平滑肌增殖是动脉粥样硬化病变发生过程中的关键事件。
Science. 1973 Jun 29;180(4093):1332-9. doi: 10.1126/science.180.4093.1332.
Zotero 插件